Searching...
8 results for “aging population”
...aging drugs is still not quite there because if you look at The US payer system, the payer that pays the most for diseases of age population is Medicare, which kicks in after 65. Before then, we have a multi payer system where, patients tend to rotat
35:13 / 36:16
from transcript35:13 – 36:16
...the fact that the population is aging, and it's very, very expensive to take care of sick people to keep sick people alive. So I think there will be these economic forces combined with more visibility, more people talking about proactive approaches t
50:11 / 51:15
from transcript50:11 – 51:15
...aging, the model does not fit. And the standard approach in a way need needs an update. That's what I said. Right? We need to move into medicine two point o, and that's really what we're trying to do. And you talk about aging. Well, one of the most d
5:14 / 6:16
from transcript5:14 – 6:16
...process of aging and how to deal with it and how to potentially slow it down.
53:58 / 55:03
from transcript53:58 – 55:03
to biology of aging, biology of longevity, whatever you wanna call it. We should allocate at least as much to that problem as we do to cancer research. Actually, we should, we should allocate as much as we do to all of the other age related diseases
1:09:52 / 1:10:55
from transcript1:09:52 – 1:10:55
with GSK and and a few others, to name a few. So part of it is this kind of shift of getting people to say, you know what? Let's back this because the potential and the total addressable market and also the the the most important thing, the fact that
47:15 / 48:15
from transcript47:15 – 48:15
...aging people. Right? It used to be that you were you were taken care of in the family. We We don't do that anymore. Now we have nursing homes. Right? Like, it's very rare that someone moves in when they're at a certain age with their with their child
27:46 / 29:02
from transcript27:46 – 29:02
...make aging the new COVID because you know? So what you like about the, side effects, you know, about the people who suffered from the vaccines that were produced, the fact is that was a teeny tiny fraction of the number of lives that were saved as a
1:04:29 / 1:05:44
from transcript1:04:29 – 1:05:44
Have a podcast?
Run your podcast through Clypt
Get ranked clips, hooks, and ready-to-post copy from your own episodes. Free to try.